Beyond direct effects on alcohol consumption, GLP-1 RAs benefit obesity and type 2 diabetes; collectively improving outcomes for those whose liver disease has both metabolic and alcohol-related causes (MetALD).17 Here, GLP1R is linked to type 2 diabetes mellitus.